Sweden Oncology NGS Market (2025-2031) | Companies, Industry, Share, Outlook, Analysis, Forecast, Competitive Landscape, Value, Growth, Trends, Segmentation, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Sweden Country Macro Economic Indicators

3.2 Sweden Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Sweden Oncology NGS Market - Industry Life Cycle

3.4 Sweden Oncology NGS Market - Porter's Five Forces

3.5 Sweden Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Sweden Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Sweden Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Sweden Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Sweden Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increased prevalence of cancer in Sweden

4.2.2 Growing adoption of precision medicine in oncology

4.2.3 Technological advancements in next-generation sequencing (NGS) technology

4.3 Market Restraints

4.3.1 High cost associated with NGS testing

4.3.2 Limited reimbursement policies for NGS in oncology

4.3.3 Data privacy and security concerns related to genomic data

6.1 Sweden Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Sweden Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Sweden Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Sweden Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Sweden Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Sweden Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Sweden Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Sweden Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Sweden Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Sweden Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Sweden Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Sweden Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Sweden Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Sweden Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Sweden Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Sweden Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Sweden Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Sweden Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Sweden Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Sweden Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Sweden Oncology NGS Market Export to Major Countries

7.2 Sweden Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing in oncology

8.2 Adoption rate of NGS testing in oncology clinics

8.3 Number of clinical trials utilizing NGS technology in oncology

9.1 Sweden Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Sweden Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Sweden Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Sweden Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Sweden Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Sweden Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Sweden Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters